Smithfield Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197K | Sell |
664
-2
| -0.3% | -$594 | 0.01% | 372 |
|
|
2025
Q4 | $183K | Buy |
666
+207
| +45% | +$56.2K | 0.01% | 371 |
|
|
2025
Q3 | $125K | Buy |
459
+15
| +3% | +$4.08K | 0.01% | 430 |
|
|
2025
Q2 | $121K | Hold |
444
| – | – | 0.01% | 421 |
|
|
2025
Q1 | $116K | Sell |
444
-12
| -3% | -$2.96K | 0.01% | 415 |
|
|
2024
Q4 | $105K | Sell |
456
-9
| -2% | -$2.07K | 0.01% | 437 |
|
|
2024
Q3 | $103K | Buy |
465
+12
| +3% | +$2.48K | 0.01% | 449 |
|
|
2024
Q2 | $91K | Hold |
453
| – | – | ﹤0.01% | 454 |
|
|
2024
Q1 | $98K | Sell |
453
-104
| -19% | -$21.8K | 0.01% | 455 |
|
|
2023
Q4 | $118K | Buy |
557
+33
| +6% | +$7.04K | 0.01% | 406 |
|
|
2023
Q3 | $106K | Buy |
524
+31
| +6% | +$6.16K | 0.01% | 404 |
|
|
2023
Q2 | $93K | Sell |
493
-52
| -10% | -$9.61K | 0.01% | 443 |
|
|
2023
Q1 | $106K | Hold |
545
| – | – | 0.01% | 409 |
|
|
2022
Q4 | $94K | Sell |
545
-32
| -6% | -$5.56K | 0.01% | 410 |
|
|
2022
Q3 | $105K | Sell |
577
-506
| -47% | -$100K | 0.01% | 380 |
|
|
2022
Q2 | $220K | Buy |
1,083
+488
| +82% | +$103K | 0.02% | 268 |
|
|
2022
Q1 | $139K | Buy |
595
+18
| +3% | +$4.23K | 0.01% | 367 |
|
|
2021
Q4 | $132K | Hold |
577
| – | – | 0.01% | 399 |
|
|
2021
Q3 | $114K | Hold |
577
| – | – | 0.01% | 409 |
|
|
2021
Q2 | $122K | Buy |
577
+15
| +3% | +$3.17K | 0.01% | 398 |
|
|
2021
Q1 | $114K | Hold |
562
| – | – | 0.01% | 417 |
|
|
2020
Q4 | $103K | Sell |
562
-35
| -6% | -$5.95K | 0.01% | 418 |
|
|
2020
Q3 | $100K | Sell |
597
-597
| -50% | -$101K | 0.01% | 396 |
|
|
2020
Q2 | $194K | Buy |
1,194
+728
| +156% | +$130K | 0.02% | 273 |
|
|
2020
Q1 | $81K | Buy |
466
+35
| +8% | +$6.97K | 0.01% | 366 |
|
|
2019
Q4 | $86K | Buy |
431
+67
| +18% | +$13.7K | 0.01% | 428 |
|
|
2019
Q3 | $76K | Hold |
364
| – | – | 0.01% | 452 |
|
|
2019
Q2 | $71K | Hold |
364
| – | – | 0.01% | 462 |
|
|
2019
Q1 | $60K | Hold |
364
| – | – | 0.01% | 471 |
|
|
2018
Q4 | $69K | Hold |
364
| – | – | 0.01% | 419 |
|
|
2018
Q3 | $62K | Hold |
364
| – | – | 0.01% | 491 |
|
|
2018
Q2 | $60K | Hold |
364
| – | – | 0.01% | 505 |
|
|
2018
Q1 | $58K | Buy |
364
+125
| +52% | +$19.9K | 0.01% | 489 |
|
|
2017
Q4 | $35K | Buy |
+239
| New | +$34K | ﹤0.01% | 576 |
|
|
2014
Q1 | – | Sell |
-28
| Closed | -$2K | – | 830 |
|
|
2013
Q4 | $2K | Buy |
+28
| New | +$2.19K | ﹤0.01% | 804 |
|
Other funds holding CME
VCM
VPM
Smithfield Trust's CME Position: Q1 2026 in Review
Smithfield Trust reduced its CME Group (CME) stake by 0.3% in Q1 2026, selling an estimated $594 and leaving 664 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #372.
Smithfield Trust first reported a position in CME in Q4 2013 and has held it in 35 quarters since. The position peaked at $220K in Q2 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Smithfield Trust held 664 shares of CME Group worth $197K as of Q1 2026.
- Smithfield Trust sold 2 CME Group shares in Q1 2026, an estimated $594.
- CME Group made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #372 holding.
- Smithfield Trust first reported a position in CME Group in Q4 2013 and has held it in 35 quarters since.
- Smithfield Trust's CME Group position peaked at $220K in Q2 2022.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.